Sedana Medical AB (publ) (STO:SEDANA)

Sedana Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	39.72	90.98	193.96	231.18	607.74	836.18
Short-Term Investments	-	-	-	150.62	-	-
Cash & Short-Term Investments	39.72	90.98	193.96	381.8	607.74	836.18
Cash Growth	-64.52%	-53.09%	-49.20%	-37.18%	-27.32%	122.29%
Accounts Receivable	24.25	29.21	26.54	24.18	15.85	20.35
Other Receivables	6.85	12.96	8.75	6.14	6.07	7.46
Receivables	31.1	42.17	35.28	30.32	21.92	27.81
Inventory	42.46	37.87	45.56	42.98	38.6	11.09
Prepaid Expenses	5.82	1.04	1.2	1.43	1.89	2.69
Other Current Assets	-	1.69	2.2	3.1	3.27	2.97
Total Current Assets	119.1	173.75	278.2	459.62	673.42	880.74
Property, Plant & Equipment	10.95	9.76	10.63	8.33	14.72	16.79
Goodwill	27.21	25.28	26.57	-	-	-
Other Intangible Assets	3.27	3.19	3.59	3.33	2.85	1.79
Long-Term Deferred Tax Assets	0.69	0.7	0.02	0.03	0.03	0.02
Long-Term Deferred Charges	768.44	741.74	700.34	542.71	390.53	268.2
Other Long-Term Assets	0.05	0.04	0.05	0.05	0.05	0.04
Total Assets	929.69	954.46	1,019	1,014	1,082	1,168

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.68	5.27	5.95	5.17	11.27	15.04
Accrued Expenses	21.03	28.33	33.09	30.02	25.79	29.74
Current Portion of Leases	4.28	2.81	3.33	3.29	5.17	4.23
Current Income Taxes Payable	3.91	2.53	3.15	1.28	2.56	4
Other Current Liabilities	16.19	12.08	6.12	3.29	4.07	8.48
Total Current Liabilities	49.1	51.03	51.65	43.04	48.86	61.48
Long-Term Leases	1.99	1.89	2.58	1.01	3.58	4.64
Long-Term Deferred Tax Liabilities	-	0.06	0.01	0.01	-	-
Other Long-Term Liabilities	1.2	0.7	6.93	-	-	-
Total Liabilities	52.29	53.68	61.17	44.06	52.43	66.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.48	2.48	2.48	2.48	2.48	2.48
Additional Paid-In Capital	1,230	1,229	1,227	1,226	1,226	1,222
Retained Earnings	-351.08	-326.64	-267.4	-256.72	-197.11	-123.61
Comprehensive Income & Other	-4.26	-3.73	-3.79	-2.2	-2.65	0.18
Shareholders' Equity	877.4	900.78	958.23	970	1,029	1,101
Total Liabilities & Equity	929.69	954.46	1,019	1,014	1,082	1,168

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.27	4.7	5.92	4.31	8.74	8.87
Net Cash (Debt)	33.46	86.28	188.04	377.5	599	827.31
Net Cash Growth	-68.99%	-54.12%	-50.19%	-36.98%	-27.60%	124.89%
Net Cash Per Share	0.34	0.87	1.89	3.80	6.03	8.90
Filing Date Shares Outstanding	99.34	99.34	99.34	99.34	99.34	99.34
Total Common Shares Outstanding	99.34	99.34	99.34	99.34	99.34	99.34
Working Capital	70	122.72	226.55	416.58	624.56	819.26
Book Value Per Share	8.83	9.07	9.65	9.76	10.36	11.09
Tangible Book Value	846.92	872.31	928.06	966.67	1,026	1,100
Tangible Book Value Per Share	8.53	8.78	9.34	9.73	10.33	11.07
Machinery	-	20.86	19.29	16.95	17.03	15.86

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error